about
Ten Years of Linear Endobronchial Ultrasound: Evidence of Efficacy, Safety and Cost-effectivenessExcessive dynamic airway collapse in a small cohort of chronic obstructive pulmonary disease patients.Serum calprotectin, CD26 and EGF to establish a panel for the diagnosis of lung cancerFactors associated with inadequate diagnosis of COPD: On-Sint cohort analysis.Evaluation of the COPD Assessment Test and GOLD patient types: a cross-sectional analysis.Screening for Chronic Obstructive Pulmonary Disease: Validity and Reliability of a Portable Device in Non-Specialized Healthcare Settings.FDG-PET parameters predicting mediastinal malignancy in lung cancerCalprotectin: a novel biomarker for the diagnosis of pleural effusion.HLA-DQ B1*0201 and A1*0102 Alleles Are Not Responsible for Antituberculosis Drug-Induced Hepatotoxicity Risk in Spanish Population.Levels of PEDF in pleural effusions from lung adenocarcinoma and benign disease patientsEffectiveness and safety of endobronchial ultrasound-transbronchial needle aspiration: a systematic review.Highly Sensitive Marker Panel for Guidance in Lung Cancer Rapid Diagnostic Units.Residential radon and lung cancer in never smokers. A systematic review.Recommendations of diagnosis and treatment of pleural effusion. Update.COPD, emphysema and the onset of lung cancer. A systematic review.Update in the extraction of airway foreign bodies in adults.Deletion of GSTM1 and GSTT1 genes and lung cancer survival: a systematic review.Residential radon and COPD. An ecological study in Galicia, Spain.Spanish experience on the design of radon surveys based on the use of geogenic information.Occupational and Biomass Exposure in Chronic Obstructive Pulmonary Disease: Results of a Cross-Sectional Analysis of the On-Sint Study.Lichtheimia ramosa: A Fatal Case of Mucormycosis.Residential radon, EGFR mutations and ALK alterations in never-smoking lung cancer cases.A Pseudo-Outbreak of Pseudomonas putida and Stenotrophomonas maltophilia in a Bronchoscopy Unit.Residential radon and lung cancer characteristics in never smokers.Small cell lung cancer in never-smokers.Management of malignant pleural effusion by an indwelling pleural catheter: A cost-efficiency analysis.Pediatricians' attitudes and costs of bronchiolitis in the emergency department: a prospective multicentre study.Reconsidering lung cancer screening: is biannual screening possible?Isoniazid hepatotoxicity among drug users: the role of hepatitis C.Determinants of false-negative results in non-small-cell lung cancer staging by endobronchial ultrasound-guided needle aspiration.Influence of glutathione S-transferase M1 and T1 homozygous null mutations on the risk of antituberculosis drug-induced hepatotoxicity in a Caucasian population.Cost-effectiveness analysis of transbronchial needle aspiration of pulmonary lesions without endobronchial affectation.Efficacy of Double Bronchodilation (LABA+LAMA) in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Lung Cancer.Hepatitis C virus infection and isoniazid hepatotoxicity.Hepatitis C virus RNA in serum as a risk factor for isoniazid hepatotoxicity.Glutathione S-transferase M1 and T1 null genotypes increase susceptibility to drug-induced liver injury.Extraction of airway foreign bodies in adults: experience from 1987-2008.Evaluation of clinical variables according to follow-up times in COPD: results from ON-SINT cohort.Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease.Environmental tobacco smoke exposure and EGFR and ALK alterations in never smokers' lung cancer. Results from the LCRINS study.
P50
Q28087680-0590D565-2763-47C8-8DFD-B0198229C887Q35222201-17AE91B8-B731-4E83-A115-EA1212241BC2Q35620753-0B2D539C-BE4A-483C-A9E8-29A329EE3904Q35636705-781E7F09-DEF7-4269-A60F-A9B007C026CBQ35683840-719416F9-BB2D-44AE-9AE8-38019CD84B47Q35883856-30E1BF41-EED6-4D83-84A1-700994FDC230Q36216501-A7A84AFF-0EC6-4E38-B9B9-BD49B851F1FBQ36419142-7F7F6C8C-6F0C-4BFE-83DB-C863ABD3D26EQ37193472-D75DD3DA-AAC0-4E71-B979-710F8FD54275Q37259870-F6EB8D60-B831-43F8-8CAB-8385358E399FQ37465873-8B74E0C8-0D0F-4728-B0AF-9005DA68AF8CQ37602084-A0A5588D-C89E-4AC4-A5C9-E6B340D0F97CQ38170918-41F636D6-EE13-4D43-BEB5-BC92CC8D0CD3Q38201861-9FB2FDA8-BF22-44B6-9BE6-C0EF4E474E0CQ38964121-EBB3C1D2-DEAB-478C-A373-FAC6D1DEF22EQ39076104-E1901DEA-1F0E-4CDB-83D8-89F2ADD2E4ACQ39185879-D4CD405E-DE60-45FB-8C40-0B9839BDA742Q39251772-46CB129C-042E-4990-A95E-13694C7FA10FQ39342924-2565F229-FED8-4A94-A7AB-B414ED232A20Q39587193-6B1DF463-8B47-4DCB-8902-F6B1ED35B050Q40095607-71F96514-9304-403D-88FD-853556732749Q40501182-B952ADF4-93D5-458C-9626-7CD9E1353B62Q40540528-33071ABA-F796-4D6E-A5C5-5893E15E09B1Q40945646-58C7C18C-9ECC-4E7C-B172-4D379887897CQ41025585-9920CA9E-8362-4A7A-8881-F9D522848F12Q41079402-50345738-FE21-48F3-99EA-0A103E47A389Q42259244-A8592C74-2834-4C24-BDC8-7C2334E86758Q42384619-9066836E-53EC-4411-AF70-A5705B35DBD2Q44285695-3C1EF23A-C37A-4DBA-AD60-23BD0192A63BQ44895689-C77E0418-FCDF-4D0D-8408-D4E054233CD7Q44937410-FC1876C7-F37C-434F-848E-CF96047E8FD9Q44978720-34932750-3F42-4A18-9384-6CC0D7BE0DC8Q45037374-F32A8F54-2FCE-475B-B8D9-54B377789BFCQ45401161-B6F7BE6C-386C-4777-B4B3-3E790CCE1D8BQ45401683-EC366ABE-12D4-4008-9E6B-F25B50C9F70AQ46032570-3C2623C9-8C92-4647-B09B-77817B9FF1BEQ46400985-0BF091AC-FBDF-4144-95D1-3BECB91A4E70Q47131947-236BC8E9-58C8-445A-8C8D-AE3D5156F7F3Q47422642-B81E9F62-2D21-47E5-99EA-6926EF492CB3Q47682990-370B4FCE-1E6E-48CE-92A9-469614C3ADBC
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-7407-5249
@en
name
Alberto Fernandez-Villar
@ast
Alberto Fernandez-Villar
@en
Alberto Fernandez-Villar
@es
Alberto Fernandez-Villar
@nl
type
label
Alberto Fernandez-Villar
@ast
Alberto Fernandez-Villar
@en
Alberto Fernandez-Villar
@es
Alberto Fernandez-Villar
@nl
prefLabel
Alberto Fernandez-Villar
@ast
Alberto Fernandez-Villar
@en
Alberto Fernandez-Villar
@es
Alberto Fernandez-Villar
@nl
P106
P21
P31
P496
0000-0001-7407-5249